Previously, there has been limited research into the trends and patterns in treatment for patients when they are diagnosed with stage IV cancer, compared to those for early stage cancer.
Katherine Henson is a senior analyst in Public Health England’s National Cancer Registration and Analysis Service. She leads on the delivery of local cancer intelligence to NHS stakeholders in London, and also on the newly acquired primary care prescriptions dataset.
Prior to joining PHE, Katherine worked as a healthcare analyst for BUPA and has completed a PhD at the Clinical Trial Service Unit in the University of Oxford. Her research focused on the long-term risks of heart disease and lung cancer after radiotherapy treatment for cancer, specifically breast and teenage and young adult cancer.
Recently the British Journal of Cancer published a study on the short-term breast cancer survival in England in relation to ethnicity and key tumour characteristics. It shows that the excess mortality among black women with breast cancer is attributable to …